Atkins KE - Search Results

1

Optimal Respiratory Syncytial Virus intervention programmes using Nirsevimab in England and Wales.

Hodgson D, Koltai M, Krauer F, Flasche S, Jit M, Atkins KE. Hodgson D, et al. Among authors: atkins ke. Vaccine. 2022 Nov 22;40(49):7151-7157. doi: 10.1016/j.vaccine.2022.10.041. Epub 2022 Oct 31. Vaccine. 2022. PMID: 36328884 Free article.

2

Impact of rotavirus vaccination on epidemiological dynamics in England and Wales.

Atkins KE, Shim E, Pitzer VE, Galvani AP. Atkins KE, et al. Vaccine. 2012 Jan 11;30(3):552-64. doi: 10.1016/j.vaccine.2011.11.064. Epub 2011 Nov 28. Vaccine. 2012. PMID: 22133508

3

The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales.

Atkins KE, Shim E, Carroll S, Quilici S, Galvani AP. Atkins KE, et al. Vaccine. 2012 Nov 6;30(48):6766-76. doi: 10.1016/j.vaccine.2012.09.025. Epub 2012 Sep 21. Vaccine. 2012. PMID: 23000223

4

Seasonal influenza vaccination delivery through community pharmacists in England: evaluation of the London pilot.

Atkins K, van Hoek AJ, Watson C, Baguelin M, Choga L, Patel A, Raj T, Jit M, Griffiths U. Atkins K, et al. BMJ Open. 2016 Feb 16;6(2):e009739. doi: 10.1136/bmjopen-2015-009739. BMJ Open. 2016. PMID: 26883237 Free PMC article.

5

Cost-effectiveness of next-generation vaccines: The case of pertussis.

Fitzpatrick MC, Wenzel NS, Scarpino SV, Althouse BM, Atkins KE, Galvani AP, Townsend JP. Fitzpatrick MC, et al. Among authors: atkins ke. Vaccine. 2016 Jun 17;34(29):3405-11. doi: 10.1016/j.vaccine.2016.04.010. Epub 2016 Apr 14. Vaccine. 2016. PMID: 27087151

6

Seasonal influenza vaccination in China: Landscape of diverse regional reimbursement policy, and budget impact analysis.

Yang J, Atkins KE, Feng L, Pang M, Zheng Y, Liu X, Cowling BJ, Yu H. Yang J, et al. Among authors: atkins ke. Vaccine. 2016 Nov 11;34(47):5724-5735. doi: 10.1016/j.vaccine.2016.10.013. Epub 2016 Oct 13. Vaccine. 2016. PMID: 27745951 Free article.

7

Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted.

Thomas SL, Walker JL, Fenty J, Atkins KE, Elliot AJ, Hughes HE, Stowe J, Ladhani S, Andrews NJ. Thomas SL, et al. Among authors: atkins ke. Vaccine. 2017 Jan 23;35(4):680-686. doi: 10.1016/j.vaccine.2016.11.057. Epub 2016 Dec 20. Vaccine. 2017. PMID: 28007397 Free PMC article.

8

Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis.

Hodgson D, Baguelin M, van Leeuwen E, Panovska-Griffiths J, Ramsay M, Pebody R, Atkins KE. Hodgson D, et al. Among authors: atkins ke. Lancet Public Health. 2017 Feb;2(2):e74-e81. doi: 10.1016/S2468-2667(16)30044-5. Lancet Public Health. 2017. PMID: 28299371 Free PMC article.

9

Use of mathematical modelling to assess the impact of vaccines on antibiotic resistance.

Atkins KE, Lafferty EI, Deeny SR, Davies NG, Robotham JV, Jit M. Atkins KE, et al. Lancet Infect Dis. 2018 Jun;18(6):e204-e213. doi: 10.1016/S1473-3099(17)30478-4. Epub 2017 Nov 13. Lancet Infect Dis. 2018. PMID: 29146178 Review.

10

Vaccination to reduce antimicrobial resistance.

Atkins KE, Flasche S. Atkins KE, et al. Lancet Glob Health. 2018 Mar;6(3):e252. doi: 10.1016/S2214-109X(18)30043-3. Lancet Glob Health. 2018. PMID: 29433663 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page